Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolien T van Ravesteyn

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
JAMA Internal Medicine|January 11, 2013
Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and controlJeanne S Mandelblatt, Anna N A Tosteson, Nicolien T van Ravesteyn
The New England Journal of Medicine|January 21, 2011
More on screening mammographyNicolien T van Ravesteyn, Eveline A M Heijnsdijk, Harry J de Koning
European Journal of Public Health|August 11, 2012
The population and high-risk approaches to prevention: quantitative estimates of their contribution to population health in the Netherlands, 1970-2010Johan P Mackenbach, Hester F Lingsma, Nicolien T van Ravesteyn, et al.
International Journal of Cancer|December 12, 2025
Quality-adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen NorwayRick Groeneweg, Nicolien T van Ravesteyn, Lindy M Kregting, et al.
BMC Cancer|October 14, 2015
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulationArantzazu Arrospide, Montserrat Rue, Nicolien T van Ravesteyn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 20, 2022
Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female populationMarloes E Clarijs, Lindy M Kregting, Nicolien T van Ravesteyn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-FadiaJeroen J van den Broek, Nicolien T van Ravesteyn, Eveline A Heijnsdijk, et al.
Developmental Medicine and Child Neurology|September 15, 2009
Measuring mobility limitations in children with cerebral palsy: interrater and intrarater reliability of a mobility questionnaire (MobQues)Nicolien T Van Ravesteyn, Annet J Dallmeijer, Vanessa A Scholtes, et al.
BMC Cancer|June 3, 2016
Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysisArantzazu Arrospide, Montserrat Rue, Nicolien T van Ravesteyn, et al.
Journal of Medical Screening|October 19, 2016
Breast cancer incidence trends in Norway and estimates of overdiagnosisPaula A van Luijt, Eveline Am Heijnsdijk, Nicolien T van Ravesteyn, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
JAMA Internal Medicine|January 11, 2013
Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and controlJeanne S Mandelblatt, Anna N A Tosteson, Nicolien T van Ravesteyn
The New England Journal of Medicine|January 21, 2011
More on screening mammographyNicolien T van Ravesteyn, Eveline A M Heijnsdijk, Harry J de Koning
European Journal of Public Health|August 11, 2012
The population and high-risk approaches to prevention: quantitative estimates of their contribution to population health in the Netherlands, 1970-2010Johan P Mackenbach, Hester F Lingsma, Nicolien T van Ravesteyn, et al.
International Journal of Cancer|December 12, 2025
Quality-adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen NorwayRick Groeneweg, Nicolien T van Ravesteyn, Lindy M Kregting, et al.
BMC Cancer|October 14, 2015
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulationArantzazu Arrospide, Montserrat Rue, Nicolien T van Ravesteyn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 20, 2022
Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female populationMarloes E Clarijs, Lindy M Kregting, Nicolien T van Ravesteyn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-FadiaJeroen J van den Broek, Nicolien T van Ravesteyn, Eveline A Heijnsdijk, et al.
Developmental Medicine and Child Neurology|September 15, 2009
Measuring mobility limitations in children with cerebral palsy: interrater and intrarater reliability of a mobility questionnaire (MobQues)Nicolien T Van Ravesteyn, Annet J Dallmeijer, Vanessa A Scholtes, et al.
BMC Cancer|June 3, 2016
Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysisArantzazu Arrospide, Montserrat Rue, Nicolien T van Ravesteyn, et al.
Journal of Medical Screening|October 19, 2016
Breast cancer incidence trends in Norway and estimates of overdiagnosisPaula A van Luijt, Eveline Am Heijnsdijk, Nicolien T van Ravesteyn, et al.
Pageof 8